Equifax (NYSE:EFX) EVP John Gamble, Jr. Sells 4,500 Shares
π EVP John Gamble, Jr. sold 4,500 shares of Equifax stock for $845,820 on September 3rd under a pre-arranged Rule 10b5-1 trading plan.
π° The company reported Q2 earnings of $2.25 per share, surpassing the consensus estimate of $2.20 by $0.05.
π Equifax revenue reached $1.70 billion for the quarter, representing a 10.6% increase compared to the same period last year.
π¦ The firm achieved a return on equity of 21.61% and a net margin of 10.73% during the reported quarter.
π Analysts have set an average price target of $215.16 with a consensus rating of 'Moderate Buy' for Equifax shares.
π΅ Equifax announced a quarterly dividend of $0.56 per share, payable on September 15th to investors of record as of August 31st.
π JPMorgan Chase cut its price target from $230.00 to $210.00 while Morgan Stanley and Citigroup also lowered their objectives recently.
ποΈ Institutional investors own 96.20% of Equifax's outstanding stock, with significant holdings from Canada Post and the Canada Pension Plan Investment Board.
π The stock currently trades at a price-to-earnings ratio of 30.19 with a market capitalization of $20.18 billion.
- Equifax reported Q2 earnings of $2.25 per share, beating analyst consensus estimates by $0.05.
- The company achieved revenue growth of 10.6% year-over-year, reaching $1.70 billion for the quarter.
- Equifax demonstrated strong profitability with a return on equity of 21.61% and a net margin of 10.73%.
- The firm maintains a high institutional ownership level of 96.20%, signaling strong investor confidence.
- Major hedge funds including Canada Post Corp Registered Pension Plan significantly increased their stakes in the company.
- JPMorgan Chase reduced its price target from $230.00 to $210.00 following recent earnings.
- Morgan Stanley lowered its price objective from $243.00 to $225.00 while maintaining an overweight rating.
- Citigroup cut its target price from $238.00 to $220.00 despite assigning a buy rating to the stock.
- Needham & Company LLC reduced its price objective from $265.00 to $245.00 in a recent research report.